These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15078197)

  • 1. Expression of cytochrome P450 in lung tumor.
    Gharavi N; El-Kadi AO
    Curr Drug Metab; 2004 Apr; 5(2):203-10. PubMed ID: 15078197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of lung cancer patients and concomitant use of drugs interacting with cytochrome P450 isoenzymes.
    Song X; Varker H; Eichelbaum M; Stopfer P; Shahidi M; Wilson K; Kaiser R; Finnern HW
    Lung Cancer; 2011 Oct; 74(1):103-11. PubMed ID: 21382644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytochrome P450 in non-small cell lung cancer.
    Oyama T; Sugio K; Isse T; Matsumoto A; Nose N; Uramoto H; Nozoe T; Morita M; Kagawa N; Osaki T; Muto M; Yasumoto K; Kawamoto T
    Front Biosci; 2008 May; 13():5787-93. PubMed ID: 18508622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 in Cancer Susceptibility and Treatment.
    Mittal B; Tulsyan S; Kumar S; Mittal RD; Agarwal G
    Adv Clin Chem; 2015; 71():77-139. PubMed ID: 26411412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between 3,4‑dichlorophenyl‑propenoyl‑sec.‑butylamine (3,4‑DCPB), an antiepileptic drug, and cytochrome P450 in rat liver microsomes and recombinant human enzymes in vitro.
    Cheng HX; Lu YY; Wang X; Ren H; Li Q; Wang SM; Ding Y; Lou YQ; Zhang GL
    Eur J Pharm Sci; 2018 Oct; 123():241-248. PubMed ID: 30010032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 isoenzyme mRNA expression pattern in human urinary bladder malignancies and normal urothelium.
    Brauers A; Manegold E; Buettner R; Baron JM; Merk HF; Jakse G
    Cancer Detect Prev; 2000; 24(4):356-63. PubMed ID: 11059566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
    Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
    Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of cyclooxygenase isoenzymes and downstream enzymes in human lung tumors.
    Ermert L; Dierkes C; Ermert M
    Clin Cancer Res; 2003 May; 9(5):1604-10. PubMed ID: 12738712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Widespread basal cytochrome P450 expression in extrahepatic bovine tissues and isolated cells.
    Kuhn MJ; Putman AK; Sordillo LM
    J Dairy Sci; 2020 Jan; 103(1):625-637. PubMed ID: 31677841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of in vitro drug interactions with karenitecin, a novel, highly lipophilic camptothecin derivative in phase II clinical development.
    Smith JA; Newman RA; Hausheer FH; Madden T
    J Clin Pharmacol; 2003 Sep; 43(9):1008-14. PubMed ID: 12971034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 in non-small cell lung cancer related to exogenous chemical metabolism.
    Oyama T; Uramoto H; Kagawa N; Yoshimatsu T; Osaki T; Nakanishi R; Nagaya H; Kaneko K; Muto M; Kawamoto T; Tanaka F; Gotoh A
    Front Biosci (Schol Ed); 2012 Jun; 4(4):1539-46. PubMed ID: 22652890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 CYP1B1 protein expression: a novel mechanism of anticancer drug resistance.
    McFadyen MC; McLeod HL; Jackson FC; Melvin WT; Doehmer J; Murray GI
    Biochem Pharmacol; 2001 Jul; 62(2):207-12. PubMed ID: 11389879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of liposomal curcumin cytochrome p450 metabolism.
    Mach CM; Chen JH; Mosley SA; Kurzrock R; Smith JA
    Anticancer Res; 2010 Mar; 30(3):811-4. PubMed ID: 20393001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P450 enzyme expression patterns in the NCI human tumor cell line panel.
    Yu LJ; Matias J; Scudiero DA; Hite KM; Monks A; Sausville EA; Waxman DJ
    Drug Metab Dispos; 2001 Mar; 29(3):304-12. PubMed ID: 11181500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of V79 cells with stably transfected cytochrome P450 cDNAs in studying the metabolism and effects of cytotoxic drugs.
    Philip PA; Ali-Sadat S; Doehmer J; Kocarek T; Akhtar A; Lu H; Chan KK
    Cancer Chemother Pharmacol; 1999; 43(1):59-67. PubMed ID: 9923542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cytochrome P450 in tumor tissues and its association with cancer development.
    Oyama T; Kagawa N; Kunugita N; Kitagawa K; Ogawa M; Yamaguchi T; Suzuki R; Kinaga T; Yashima Y; Ozaki S; Isse T; Kim YD; Kim H; Kawamoto T
    Front Biosci; 2004 May; 9():1967-76. PubMed ID: 14977602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of active hexose correlated compound hepatic metabolism and potential for drug interactions with chemotherapy agents.
    Mach CM; Fugii H; Wakame K; Smith J
    J Soc Integr Oncol; 2008; 6(3):105-9. PubMed ID: 19087767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue.
    Kivistö KT; Linder A; Friedel G; Beaune P; Belloc C; Kroemer HK; Fritz P
    Virchows Arch; 1995; 426(3):243-7. PubMed ID: 7773503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 and anticancer drugs.
    Fujita K
    Curr Drug Metab; 2006 Jan; 7(1):23-37. PubMed ID: 16454691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.